Guanosine (cas 118-00-3) exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling
-
Add time:08/30/2019 Source:sciencedirect.com
BackgroundGuanosine (cas 118-00-3) is a natural product and an endogenous nucleoside that has shown to increase during myocardial ischemia. Platelets are critically involved in ischemic coronary events. It remains unknown, however, whether guanosine may affect platelet activation and function. We sought to investigate the potential antiplatelet and antithrombotic properties of guanosine and decipher the mechanisms behind.
We also recommend Trading Suppliers and Manufacturers of Guanosine (cas 118-00-3). Pls Click Website Link as below: cas 118-00-3 suppliers
Prev:Research paperChikungunya virus inhibition by synthetic coumarin–Guanosine (cas 118-00-3) conjugates
Next:Citrate/Tb Lanthanide Coordination Polymer Nanoparticles: Preparation and Sensing of Guanosine (cas 118-00-3)-5-Monophosphate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Guanosine (cas 118-00-3) protects against Ca2+-induced mitochondrial dysfunction in rats09/03/2019
- Elevated plasma cyclic Guanosine (cas 118-00-3) monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report☆09/02/2019
- Regular ArticleGuanosine (cas 118-00-3)-based thermotropic liquid crystals with tunable phase structures and ion-responsive properties09/01/2019
- Citrate/Tb Lanthanide Coordination Polymer Nanoparticles: Preparation and Sensing of Guanosine (cas 118-00-3)-5-Monophosphate08/31/2019
- Research paperChikungunya virus inhibition by synthetic coumarin–Guanosine (cas 118-00-3) conjugates08/29/2019
- Research reportLong lasting behavioral and electrophysiological action of early administration of Guanosine (cas 118-00-3): Analysis in the adult rat brain08/28/2019
- RESEARCH ARTICLEGuanosine (cas 118-00-3) Prevents against Glutamatergic Excitotoxicity in C. elegans08/27/2019
- Augmentation effect of ketamine by Guanosine (cas 118-00-3) in the novelty-suppressed feeding test is dependent on mTOR signaling pathway08/26/2019
-
Health and Chemical more >


